ORBIMED ADVISORS LLC

Q3 2026 13F-HR Detailed Holdings

Location
New York, NY
Holdings as of
9/30/2026
Date filed
11/16/2026
Form type
13F-HR
Num holdings
124
Total value ($000)
$5,498,487
Net value change ($000)
+101,707 (1.9%)
New positions
29
Sold out positions
32
Turnover %
38.8%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
ADARX PHARMACEUTICALS INC 482,663 NEW
BRAVEHEART BIO INC 245,938 NEW
ELECTRA THERAPEUTICS INC 77,458 NEW
TNGX 69,302 NEW
ABBV 67,909 NEW
CDNA 60,762 NEW
ABT 57,223 NEW
TVTX 56,308 391.8%
MRK 52,231 61.3%
BLOSSOMHILL THERAPEUTICS INC 50,594 NEW
Top Reduces (Value $000, Stocks/ETFs)
AZN -109,297 -63.9%
SION -99,441 -88.4%
GPCR -76,958 -64.9%
DYN -71,865 -100.0%
CGON -69,117 -100.0%
QURE -63,659 -76.5%
BSX -63,303 -100.0%
ABVX -54,509 -74.8%
XENE -53,870 -100.0%
BMY -53,299 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 45,654 (0.8% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 ORBIMED CAPITAL LLC 028-10410